Doç. Dr. Murat KOÇER

Yayın Ağı

Makaleler 24

1. Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA)

Ozaslan E., ÖZKAN M., ÇİÇİN İ., BENEKLİ M., Kocer M., UYSAL M., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.24, sa.6, ss.973-979, 2018 (SCI-Expanded, Scopus)

2. A Different Cause of Malignant Hypercalcemia in a Breast Carcinoma with Bone Metastasis

AYDIN B., Cerci S. S., Kocer M., KALE B., TALİP BÜLBÜL P., ÇOLAK F., et al.

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM , cilt.22, sa.1, ss.41-44, 2018 (ESCI, Scopus, TRDizin)

3. Medication related osteonecrosis of the jaws: a case serial study

Aksoy M. C., KOÇER G., Kocer M., BAYKUL T.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.10, sa.11, ss.15672-15679, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

4. Using Interferon Alfa Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Cell Carcinoma: A Turkish Oncology Group (TOG) Study

ARTAÇ M., COŞKUN H. Ş., Korkmaz L., Kocer M., Turhal N. S., ENGİN H., et al.

CLINICAL GENITOURINARY CANCER , cilt.14, sa.4, 2016 (SCI-Expanded, Scopus)

5. Factors Affecting Survival in Small Cell Lung Cancer

Sakin A., Turgut E. S., Aybek M., Usta A. A., Kosan O., Celik K., et al.

EUROPEAN JOURNAL OF GENERAL MEDICINE , cilt.13, sa.3, ss.37-41, 2016 (ESCI, Scopus) Sürdürülebilir Kalkınma

6. Regenerated bisphosphonate reiated osteonecrosis of the jaws clinical data of eleven caese

ÇINA AKSOY M., KOÇER G., KOÇER M., BAYKUL T.

BJMMR , 2015 (Hakemli Dergi)

7. Clinicopathologic significance of high CD133 expression in colorectal carcinomas

DEVRİM T., KARAHAN N., BAŞPINAR Ş., BOZKURT K. K., KOÇER M., Kapucuoğlu N.

SDÜ Tıp Fak Derg , cilt.22, sa.2, ss.32-38, 2015 (Hakemli Dergi)

8. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast CD44/CD24 expression in breast cancer

Kapucuoglu N., BOZKURT K. K., BAŞPINAR Ş., Kocer M., Eroglu H. E., Akdeniz R., et al.

PATHOLOGY RESEARCH AND PRACTICE , cilt.211, sa.10, ss.740-747, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. Regenerated Bisphosphonate Related Osteonecrosis of the Jaws: Clinical Data of Eleven Cases

ÇINA AKSOY M., KOÇER G., KOÇER M., BAYKUL T.

British Journal of Medicine and Medical Research , cilt.10, sa.8, ss.1-8, 2015 (Hakemli Dergi)

10. Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology

Kaplan M. A., Isikdogan A., Koca D., KÜÇÜKÖNER M., Gumusay O., Yildiz R., et al.

BREAST CANCER , cilt.21, sa.6, ss.677-683, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. EXTENSIVENESS OF DISEASE, PERFORMANCE SCORE AND EFFECT OF CHEMOTHERAPY ON SURVIVAL IN PATIENTS WITH SMALL CELL LUNG CANCER

Turgut E. S., Kocer M., Aybek M., Sakin A., Usta A. A.

JOURNAL OF THORACIC ONCOLOGY , cilt.9, sa.9, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. Immunohistochemical expression of caspase-3, caspase-5, caspase-7 and apoptotic protease-activating factor-1 (APAF-1) in the liver and kidney of rats exposed to zoledronic acid (ZOL) and basic fibroblast growth factor (bFGF)

AYDOĞAN A., KOÇER G., ÖZMEN Ö., Kocer M., Onal L., Koskan O.

VETERINARY QUARTERLY , cilt.34, sa.3, ss.137-142, 2014 (SCI-Expanded, Scopus)

13. Paratesticular myxofibrosarcoma

BAŞPINAR Ş., Kapucuoglu N., Akdeniz R., OKSAY T., Guzel A., Kocer M.

INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY , cilt.57, sa.3, ss.503-504, 2014 (SCI-Expanded, Scopus)

14. Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study

ARTAÇ M., Turha N. S., Kocer M., KARABULUT B., Bozcuk H., Yalcin S., et al.

TUMORI J , cilt.100, sa.2, ss.143-148, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. Effects of Bisphosphonate on Oxidative Stress Levels in Patients With Different Types of Cancer

Kocer M., NAZIROĞLU M., KOÇER G., Soenmez T. T.

CANCER INVESTIGATION , cilt.32, sa.2, ss.37-42, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Multicenter Epidemiologic Study on Hepatocellular Carcinoma in Turkey

Can A., Dogan E., Bayoglu I. V., Tatli A. M., Besiroglu M., Kocer M., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.6, ss.2923-2927, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. Effects of 5-Fluorouracil on Oxidative Stress and Calcium Levels in the Blood of Patients with Newly Diagnosed Colorectal Cancer

Kocer M., NAZIROĞLU M.

BIOLOGICAL TRACE ELEMENT RESEARCH , cilt.155, sa.3, ss.327-332, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. Basic Fibroblast Growth Factor Attenuates Bisphosphonate-Induced Oxidative Injury but Decreases Zinc and Copper Levels in Oral Epithelium of Rat

KOÇER G., NAZIROĞLU M., ÇELİK Ö., ÖNAL L., Ozcelik D., Kocer M., et al.

BIOLOGICAL TRACE ELEMENT RESEARCH , cilt.153, ss.251-256, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Clinicopathological Features of Patients with Malignant Mesothelioma in a Multicenter, Case-Control Study: No Role for ABO-Rh Blood Groups

Utkan G., ÜRÜN Y., CANGIR A., Kilic D., Ozdemir N. Y., ÖZTUNA D., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.1, ss.249-253, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. Acute transient encephalopathy after weekly paclitaxel infusion

Muallaoglu S., Kocer M., Guler N.

MEDICAL ONCOLOGY , cilt.29, sa.2, ss.1297-1299, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. Lack of Any Relationship between ABO and Rh Blood Groups and Clinicopathological Features in Patients with Gastrointestinal Stromal Tumors: Turkish Oncology Group

ÜRÜN Y., Utkan G., YALÇIN Ş., COŞKUN H. Ş., Kocer M., Ozdemir N. Y., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.13, sa.8, ss.4129-4131, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. Biological Subtypes and Survival Outcomes in Breast Cancer Patients with Brain Metastases (Study of the Anatolian Society of Medical Oncology)

Kaplan M. A., Isikdogan A., Koca D., Kucukoner M., Gumusay O., Yildiz R., et al.

ONCOLOGY , cilt.83, sa.3, ss.141-150, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

23. Optimal timing of adjuvant treatment in patients with early breast cancer

Alkis N., Durnali A. G., Arslan U. Y., Kocer M., Onder F. O., Tokluoglu S., et al.

MEDICAL ONCOLOGY , cilt.28, sa.4, ss.1255-1259, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

24. Primary adult soft tissue sarcomas: analysis of 294 patients

Alkis N., Muallaoglu S., Kocer M., Arslan U. Y., Durnali A. G., Tokluoglu S., et al.

MEDICAL ONCOLOGY , cilt.28, sa.1, ss.391-396, 2011 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 21

1. Hodglenfoma, Prolaktinoma ve Pankreas Adenokarsinomu Birlikteliği

ALANOĞLU E. G., ÇERÇİ S. S., CİRİŞ M., KOÇER M.

43. Ulusal Hematoloji Kongresi, Türkiye, 1 - 04 Kasım 2017, (Özet Bildiri)

2. Effectiveness and safety of LMWH treatment in patients with cancer diagnosed with nonhigh-risk venous thromboembolism (VTE): Results of the Turkish observational study (TREBECA).

Ozaslan E., Ozkan M., Cicin I., Benekli M., Kocer M., Uysal M., et al.

53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 2 - 07 Haziran 2017, cilt.35, (Özet Bildiri) Sürdürülebilir Kalkınma

3. Onkoloji Servisinde Yatan Hastalarda Potansiyel İlaç İlaç Etkileşimlerinin Araştırılması

AŞCI H., CANKARA F. N., SÖNMEZ Y., SAYGIN M., argüz g., yorgancıgil e., et al.

Türk Farmakoloji Derneği 23. Ulusal Farmakoloji Kongresi, Türkiye, 7 - 10 Eylül 2015, ss.230, (Özet Bildiri)

4. Association of obesity with breast cancer clinical and pathological factors: Analysis of Turkish National Breast Cancer Registry.

Coskun U., Altundag K., Aliustaoglu M., Uncu D., Ozkan M., Cicin I., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri) Sürdürülebilir Kalkınma

5. Effect of body mass index in gastric cancer patients: Analysis of Turkish national gastric cancer registry

Ciltas A., Karaca M., Uncu D., Ozkan M., Aliustaoglu M., Tekin S. B., et al.

6. Association of age with breast cancer clinical and pathological factors: Analysis of Turkish National Breast Cancer Registry.

Benekli M., Altundag K., Dumanli E., Isikdogan A., Karaoglu A., Tekin S. B., et al.

7. Turkish National Colon Cancer Registry.

Benekli M., Dumanli E., Kilickap S., Uncu D., Aliustaoglu M., Cicin I., et al.

8. Turkish National Breast Cancer Registry.

Altundag K., Dumanli E., Aliustaoglu M., Uncu D., Ozkan M., Cicin I., et al.

9. Geographic variations of clinical characteristics in breast cancer: Analysis of Turkish National Breast Cancer Registry.

Kilickap S., Altundag K., Dumanli E., Gumus M., Uslu R., Ozyilkan O., et al.

10. Özgür ARICI Murat KOÇER Nilgün KAPUCUOĞLU Hikmet ORHAN Hasan Şenol COŞKUN SÜlaymen Demirel Üniversitesi Tıp Fakültesi Medikal Onkoloji Ünitesine başvuran İnvaziv Meme Kanserli hastalardaki prognostik faktörlerin progresyonsuz sağkalım ve genel sağkalıma etkisi

ARICI Ö., KOÇER M., KAPUCUOĞLU N., ORHAN H., COŞKUN H. Ş.

2. İmmunoloji Onkoloji Kongresi. 13-17.05.2015. Antalya., Türkiye, 13 - 17 Mayıs 2015, (Özet Bildiri) Sürdürülebilir Kalkınma

15. Memenin İnvaziv Duktal Karsinomunda CD24 CD44 CD133 ALDH1 İmmünhistokimyasal Ekspresyonunun Klinikopatolojik Parametreler ve Prognozla İlişkisi

KAPUCUOĞLU N., BOZKURT K. K., BAŞPINAR Ş., KOÇER M., EROĞLU H. E., AKDENİZ R., et al.

23. Ulusal Patoloji Kongresi, Türkiye, 6 - 10 Kasım 2013

16. Lapatinib or trastuzumab? Which anti-HER2 treatment is more effective in the treatment of patients with HER2-positive breast cancer with brain metastases? An Anatolian Society of Medical Oncology Study

Kaplan M. A., Isikdogan A., Koca D., Kucukoner M., Gumusay O., Yildiz R., et al.

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri) Sürdürülebilir Kalkınma